BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 45432)

  • 1. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypotensive effects of timolol in 86 patients (author's transl)].
    Lagrue G; Gumpelson A; Kazandjan M; Grillot A
    Sem Hop; 1978 Oct 8-15; 54(29-32):929-32. PubMed ID: 216083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
    Szám I; Pálossy B
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1719-22. PubMed ID: 105251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antihypertensive effect of a fixed combination of beta receptor blockaders and diuretics on the resting and exertion blood pressure of patients with essential hypertension].
    Franz IW
    Schweiz Med Wochenschr; 1980 Nov; 110(44):1616-22. PubMed ID: 6109375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cicletanine administered with other antihypertensive agents].
    Grimberg D; Tarrade T; Deschamps de Paillette E
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():109-12. PubMed ID: 2575368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of ambulatory registration of arterial pressure in therapeutic trials of antihypertensive agents].
    Rion F; Waeber B; Graf HJ; Jaussi A; Porchet M; Brunner HR
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1829-31. PubMed ID: 4089582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potassium metabolism during antihypertensive treatment with beta-receptor blocker and diuretic treatment].
    Middeke M; Holzgreve H
    Dtsch Med Wochenschr; 1981 Mar; 106(13):396-400. PubMed ID: 6111438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations on physiopathological approaches to the treatment of hypertension.
    Zanchetti A; Leonetti G; Morganti A; Terzoli L
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-hypertensive effect of timolol maleate (blocadren) in gradated combination with a diuretic].
    Vorburger C
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1474-81. PubMed ID: 1013666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.